| http://www.w3.org/ns/prov#value | - (ii) Agency actions relevant to the Regulatory Flexibility Act, 5 U.S.C. 603-605, 607, and 609 The FDA performed a Final Regulatory Flexibility Analysis of the final rule, which contains the information required by the Act including the number and types of small entities affected, the
|
